seen are indicative of a hepatotoxic effect. Similar lysosomal and ultrastructural changes were observed in rats treated with 50 or 100p.p.m. of cournarin for 2 weeks. These changes were accompanied by liver enlargement and a marked depression of microsomal mixed-function oxidase activity.
It has been shown that mammary carcinomas induced in female Sprague-Dawley rats by the administration of the carcinogen dimethylbemthracene may metabolize steroid hormones (King et al., 1964 (King et al., ,1965 . The aim of the present study was to determine the effects of increasing the circulating amounts of prolactin upon the metabolism of dehydroepiandrosterone and testosterone in these tumours.
Two groups of female Sprague-Dawley rats, in whom adenocarcinoma were induced by dirnethylbenzanthracene (Smg intravenously at 50 days of age), were investigated. One group received perphenazine (fentazin) in daily subcutaneous injections (5mg/kg body wt.) from the age of 30 days to raise circulating prolactin amounts. The control group received only vehicle (0.2 % citric acid). A comparison of tumours believed to be induced and grown in the presence of high and normal amounts of circuIating prolactin was therefore possible.
The metabolism of dehydroepiandrosterone and testosterone in vitro was determined in ten adenocarcinomas from both groups of animals. A portion (1 g) of each tumour was finely sliced in 1Oml of Krebs-Ringer phosphate buffer. An NADPH-generating system (2OOpmol of glucose 6-phosphate, 25pg of NADP+ and 50 units of glucose 6-phosphate dehydrogenase) and 45 Ci of either [7-3H]dehydroepiandrosterone or [7-3H]testosterone were added. Incubation was immediately performed at 37°C for 2h in 02.
The steroid interconversions were determined by measuring the percentage incorporation of radioactive label into the individual metabolites after extraction and purification by t.1.c. Details of the methods of steroid purification and characterization have been described by Fahmy et al. (1968) and Jones et al. (1970) .
The metabolism of [7-3H]dehydroepiandrosterone was not influenced by perphenazine treatment, no differences being found either in the amount of metabolism of dehydroepiandrosterone or the production of metabolites of dehydroepiandrosterone.
The results from the incubations with testosterone are presented in Table 1 . The carcinomas from the perphenazine-treated animals displayed significantly greater metabolism of testosterone than those from control animals. The amount of metabolism varied considerably within each group, the variation being not only between individual animals but between tumours from different sites within the same animal. Of the metabolities of testosterone the mean production of 5a-dihydrotestosterone was higher (but not significantly so) in tumours from the perphenazine-treated animals. The conversion into 5a-androstandiol was, however, significantly increased in the perphenazine-treated rats. By combining the production of Su-dihydrotestosterone and Su-androstandiol and expressing the result as % Su-reduction, an estimate of total Sa-reductase activity was obtained. This was significantly higher in the perphenazine-treated group as compared with the control group. The conversion of testosterone into A-4-androstenedione was also investigated. Although the mean amount of oxidation into A-Candrostenedione was significantly higher in the perphenazine group, this was accounted for by two tumours, in which the amount of oxidation was markedly raised. These two tumours had the lowest Sa-reductase activity of the perphenazine group.
It is possible that the increased Su-reductase activity demonstrated in tumours from perphenazine-treated animals is caused by differences in tumour cellularity. The findings of similar metabolism of another C-19 steroid precursor, dehydroepiandrosterone, and thesimilar conversionof testosteroneinto A-4-androstenedionein bothgroupsof tumours would, however, indicate that the effects on Su-reduction of testosterone are relatively specific. Further evidence for this has come from preliminary studies in which ovine prolactin (SOpg/ml) has been added to incubation mixtures of dimethylbenzanthracene adenocarcinomas in vitro with similar effects on testosterone metabolism.
Prolactin has been shown to influence the metabolism of testosterone in other steroidmetabolizing organs. For example, Boyns et al. (1972) have demonstrated that prolactin not only increased uptake of testosterone in rat prostatic cultures but changed the ratio of 5u-dihydrotestosterone to testosterone in favour of the non-reduced form. This effect upon Su-reduction in the prostate is opposite to that demonstrated in the present study of rat mammary tissue.
